Log in to save to my catalogue

Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly dia...

Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly dia...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3171885167

Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW)

Publication information

Publisher

United States

More information

Scope and Contents

Contents

The STANDLOW trial investigated whether first-line antiseizure monotherapy with low doses has a similar efficacy to standard doses, but with fewer adverse events, improved quality of life, and reduced costs for the National Health System.
Multicenter, randomized, parallel-arm, single-blind, non-inferiority trial, comparing low dose versus standa...

Alternative Titles

Full title

Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3171885167

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3171885167

Other Identifiers

ISSN

2470-9239

E-ISSN

2470-9239

DOI

10.1002/epi4.70016

How to access this item